FDA Gives 50% Of Focus To Drug Safety Under PDUFA, Agency’s Woodcock Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA devotes 50% of its energy to drug safety under the Prescription Drug User Fee Act program, FDA Acting Deputy Commissioner for Operations Janet Woodcock told the Senate Health Committee
You may also be interested in...
Vioxx Promotions, Labeling Revisions Are Focus Of Drug Safety Hearing
Three FDAers and Merck VP Erb will testify at the House Government Reform Committee hearing May 5. The committee suggests that creation of a Drug Safety Monitoring Board will not resolve all concerns with FDA’s post-marketing surveillance.
Vioxx Promotions, Labeling Revisions Are Focus Of Drug Safety Hearing
Three FDAers and Merck VP Erb will testify at the House Government Reform Committee hearing May 5. The committee suggests that creation of a Drug Safety Monitoring Board will not resolve all concerns with FDA’s post-marketing surveillance.
"Fix The FDA" Ad Campaign Seeks To Pressure Congress For Agency Funding
A print ad campaign appears targeted at inside-the beltway audiences; TV ads also are running. The sponsors of FixtheFDA.org – which include the Center for Medical Consumers and U.S. PIRG – timed the ads to follow the COX-2 inhibitor advisory committee meeting.